Menard Financial Group LLC Dexcom Inc Transaction History

Menard Financial Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $67,106 - $131,162	-987 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$94.08 - $130.2 $27,753 - $38,409	295 Added 42.63%	987 $505,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $7,662 - $9,606	-59 Reduced 7.86%	692 $372,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $15,259 - $20,474	143 Added 23.52%	751 $411,000
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $49,241 - $65,621	608 New	608 $260,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $47,346 - $63,431	-607 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $57,974 - $68,560	607 New	607 $250,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Menard Financial Group LLC with notifications on news.